Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 54 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
Apotheek Vandromme from Wevelgem, company number BE0875953748, closed financial year 2025 with a result of € 186,973 after tax. For that financial year Apotheek Vandromme recorded a gross margin of € 479,479 and equity of € 590,053. Compared with financial year 2024, the result moved from € 138,401 to € 186,973. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on October 30, 2025.
€ 590,053
▲ 46% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 186,973
▲ 35% vs 2024
Profit after tax over the fiscal year.
€ 72,224
▲ 135% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 1,666 paid out
1 % of the profit went to the shareholders, the rest stayed in the company.
People and assets in 2025
0.8
▼ 0.1 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 71,508
▲ 147% vs 2024
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 13,676
▼ 19% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 401,919
▼ 26% vs 2024
€ 66,432 is repaid this year. At this pace the long-term loan is gone in ≈ 6 years.
€ 58,907
▼ 7% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 48,269
▲ 179% vs 2024
Taxes, VAT and social contributions still to pay.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 228,368 | € 387,782 | € 371,705 | € 479,479 | ▲ 29% |
| Profit after taxes | € 64,046 | € 195,341 | € 138,401 | € 186,973 | ▲ 35% |
| Equity | € 90,269 | € 268,010 | € 404,745 | € 590,053 | ▲ 46% |
| Total debts | € 1,379,091 | € 1,199,236 | € 920,819 | € 762,220 | ▼ 17% |
| Cash | € 97,561 | € 109,280 | € 30,683 | € 72,224 | ▲ 135% |
| Land & buildings | € 936,345 | € 933,071 | € 1,027,012 | € 944,582 | ▼ 8% |
| Retained profit | € -78,331 | € 99,410 | € 236,145 | € 421,453 | ▲ 78% |
| Dividend | € 0 | € 17,600 | € 1,666 | € 1,666 | |
| Bank debt | € 1,073,984 | € 973,514 | € 543,570 | € 401,919 | ▼ 26% |
| Balance sheet total | € 1,469,361 | € 1,467,246 | € 1,325,564 | € 1,352,273 | ▲ 2% |
| Employees (FTE) | 0.8 | 0.8 | 0.9 | 0.8 | ▼ 0.1 |
By gross margin, Apotheek Vandromme ranks 2nd of 13 companies with main activity “Detailhandel in farmaceutische producten” in Wevelgem that publish figures (fiscal year 2025).
Key figures of Apotheek Vandromme, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2026 has not been filed yet; it was expected before 31 October 2026.
Ask about Apotheek Vandromme the way you would ask their accountant.
Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.
Connect ChatGPT or Claude for free- ChatGPT
- Claude
Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.
What happened to Apotheek Vandromme?
What happened at Apotheek Vandromme in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 186,973 (▲ 35% vs 2024). Source: NBB ↗
- Veroniek Vandromme became a director. NBB
- Pieter Vantieghem became a director. NBB
- Capital increase of € 150,000, published in the Gazette. Source: Staatsblad ↗
- New establishment in Wevelgem. KBO
- Incorporation, published in the Gazette. Source: Staatsblad ↗
In short
From € 64,046 profit in 2022 to € 186,973 profit in 2025.
Paid € 186,904 in corporate taxes since 2022.
Best year ever: 2023, with € 195,341 profit.
Paid out € 20,932 in dividends to the owners in total.
Management
Behind Apotheek Vandromme are Veroniek Vandromme and Pieter Vantieghem.
Directors
According to the 2025 annual accounts
Veroniek Vandromme
Director
since 2022
Pieter Vantieghem
Director
since 2022
Establishments
Establishment units
Physical locations of this company
Roeselarestraat 14
8560 Wevelgem
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Similar companies in Wevelgem
Same main activity (Detailhandel in farmaceutische producten), 15 active companies in Wevelgem, largest first.
€ 518,821 gross margin · 2025
€ 382,222 gross margin · 2025
€ 332,498 gross margin · 2025
€ 253,087 gross margin · 2025
€ 252,092 gross margin · 2025
€ 212,256 gross margin · 2025
Website
Technologies
Hosting & Email
Email provider
Self-hosted
Hosting
AMAZON-02 - Amazon.com, Inc., US
DNS
AWS Route 53
Website info
Features
Security
Network
Shareholders according to the Official Gazette deeds
Who contributed at incorporation and at capital increases, with the deed as source. Later share transfers are not published in the Gazette.
Incorporation
Source: Deed ↗- VANDROMME Veroniek Jacqueline Christiane(vennoot) 50%
- VANTIEGHEM Pieter Jan André Gerard(vennoot) 50%
Details
- Company number
- 0875.953.748
- VAT number
- BE 0875.953.748
- Registered office
- Roeselarestraat 14, 8560 Wevelgem
- Names & denominations
- Apotheek Vandromme
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 9 September 2005
- Peppol
- Active · Active since 17 Nov 2025
- Contact
- apotheekvandromme.be
- Activities · NACE
Detailhandel in farmaceutische producten
Apothekers
Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies
Verhuur en exploitatie van eigen of geleased residentieel onroerend goed, exclusief sociale woningen
Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering